Pharmaceutical companies often preach value. Yet, for seven top-selling drugs, prices went up in 2017 and 2018 despite limited new evidence showing patients receiving...

MilliporeSigma announced it has acquired FloDesign Sonics, a Wilbraham, MA-based acoustic cell processing platform developer for the industrialization of cell and gen...

Rapidly progressing gene therapy development could push more biotechs to invest in their own manufacturing capabilities over outsourcing to contract services companie...

CAUMZ is a non-opioid alternative in Phase 3 development for the treatment of pain and inflammation, and Tetra are one step closer to bringing the kit to market. CAUM...

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-thre...

 Moore Fight Moore Strong (MFMS) – an organization with a mission to carry on the legacy of their best friend, Jessica Moore, to raise awareness for Metastatic Breast...

Biogen has a new R&D leader, announcing Tuesday that Michael Ehlers will leave on Oct. 11 and, effective immediately, pass his duties on to Chief Medical Officer ...

An experimental Ebola vaccine has moved a step closer toward U.S. approval, following the Food and Drug Administration's acceptance of an application from Merck &...

Dive Brief: Thirteen biopharma companies, including Sangamo Therapeutics and Bluebird bio, signed a statement of principles opposing gene editing of human sperm, e...